Pfizer Inc (PFE)

NYSE HEALTHCARE

$24.17 -0.33% RSI 46 Neutral Add Alert

Moving Averages

SMA 50

$25.38

Price below

SMA 200

$25.87

Price below

EMA 20

$24.56

Price near

Company Profile

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company commemorates its co-founder, Charles Pfizer (1824-1906). Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than 1 billion USD in annual revenues.

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - GENERAL

Market Cap

$137.76B

P/E Ratio

18.45

EPS

$1.31

Beta

0.307

Dividend Yield

7.09%

52-Week High

$28.28

52-Week Low

$21.97

Insider Transactions

Executive	Title	Action	Shares	Date
BOURLA, ALBERT	Director, Chairman & CEO	Buy	25	2026-06-30
QUINCEY, JAMES	Director	Buy	1,595	2026-06-26
TARAPOREVALA, CYRUS	Director	Buy	1,543	2026-06-26

Continue with Google

Latest News

Pfizer (NYSE:PFE) scores FDA approval but Wall Street reaction muted
Neutral • TechStock²
Pfizer (PFE) Wins FDA Approval For First Platinum Free Bladder Cancer Regimen
Somewhat-Bullish • Simply Wall Street
Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin
Somewhat-Bullish • Treasure Coast News

Earnings Call Transcript

Pfizer Inc Q1 2026 — Good day, everyone, and welcome to Pfizer's First Quarter 2026 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Francesca DeMartino, Chief Investor Relations Officer and Senior Vice President. Please go ahead, ma'am.…

Continue with Google